Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CNS Stock Forecast 2026-2027
$66.67
Current Price
$3.43B
Market Cap
Buy 1
Hold 1
Sell 1
Wall St Analyst Ratings
Distance to CNS Price Targets
+12.5%
To High Target of $75.00
+5.0%
To Median Target of $70.00
-20.5%
To Low Target of $53.00
CNS Price Momentum
+3.3%
1 Week Change
+7.2%
1 Month Change
-10.2%
1 Year Change
+6.2%
Year-to-Date Change
-20.6%
From 52W High of $83.99
+14.2%
From 52W Low of $58.39
📊 TOP ANALYST CALLS
Did CNS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cohen & Steers is one of their latest high-conviction picks.
Latest CNS Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, CNS has a neutral consensus with a median price target of $70.00 (ranging from $53.00 to $75.00). The overall analyst rating is Buy (6.7/10). Currently trading at $66.67, the median forecast implies a 5.0% upside. This outlook is supported by 1 Buy, 1 Hold, and 1 Sell ratings.
The most optimistic forecast comes from John Dunn at Evercore ISI Group, projecting a 12.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CNS Analyst Ratings
1
Buy
1
Hold
1
Sell
CNS Price Target Range
Low
$53.00
Average
$70.00
High
$75.00
Current: $66.67
Latest CNS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CNS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 10, 2026 | Evercore ISI Group | John Dunn | Outperform | Maintains | $75.00 |
| Oct 20, 2025 | Evercore ISI Group | John Dunn | Outperform | Maintains | $77.00 |
| Oct 9, 2025 | Evercore ISI Group | John Dunn | Outperform | Maintains | $74.00 |
| Oct 2, 2025 | B of A Securities | Craig Siegenthaler | Underperform | Maintains | $68.00 |
| Sep 5, 2025 | Evercore ISI Group | John Dunn | Outperform | Maintains | $77.00 |
| Jul 21, 2025 | B of A Securities | Craig Siegenthaler | Underperform | Maintains | $66.00 |
| Jun 30, 2025 | B of A Securities | Craig Siegenthaler | Underperform | Initiates | $67.00 |
| Apr 11, 2025 | Evercore ISI Group | John Dunn | Outperform | Maintains | $78.00 |
| Nov 7, 2024 | Evercore ISI Group | John Dunn | Outperform | Maintains | $111.00 |
| Oct 17, 2024 | UBS | Brennan Hawken | Neutral | Upgrade | $102.00 |
| Oct 4, 2024 | Evercore ISI Group | John Dunn | Outperform | Maintains | $96.00 |
| Sep 5, 2024 | Evercore ISI Group | John Dunn | Outperform | Maintains | $92.00 |
| Jul 10, 2024 | UBS | Adam Beatty | Sell | Maintains | $63.00 |
| Apr 12, 2024 | UBS | Adam Beatty | Sell | Maintains | $67.00 |
| Mar 8, 2024 | Evercore ISI Group | John Dunn | Outperform | Maintains | $78.00 |
| Jan 10, 2024 | UBS | Adam Beatty | Sell | Maintains | $69.00 |
| Jan 5, 2024 | UBS | Adam Beatty | Sell | Initiates | $68.00 |
| Apr 13, 2023 | Evercore ISI Group | John Dunn | Outperform | Maintains | $68.00 |
| Nov 19, 2020 | B of A Securities | Michael Carrier | Buy | Upgrade | $76.00 |
| Apr 24, 2020 | B of A Securities | Neutral | Upgrade | $N/A |
Cohen & Steers Inc. (CNS) Competitors
The following stocks are similar to Cohen & Steers based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CNS
Cohen & Steers
mkt cap
3.43B
Cohen & Steers Inc. (CNS) Financial Data
Cohen & Steers Inc. has a market capitalization of $3.43B with a P/E ratio of 21.4x. The company generates $556.12M in trailing twelve-month revenue with a 27.6% profit margin.
Revenue growth is +2.9% quarter-over-quarter, while maintaining an operating margin of +28.0% and return on equity of +26.0%.
Valuation Metrics
Market Cap
$3.43B
Enterprise Value
$3.22B
P/E Ratio
21.4x
PEG Ratio
-0.9x
Price/Sales
6.0x
Growth & Margins
Revenue Growth (YoY)
+2.9%
Gross Margin
+45.1%
Operating Margin
+28.0%
Net Margin
+27.6%
EPS Growth
-23.9%
Financial Health
Cash/Price Ratio
+9.1%
Current Ratio
3.6x
Debt/Equity
21.8x
ROE
+26.0%
ROA
+13.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cohen & Steers Inc. (CNS) Business Model
About Cohen & Steers Inc.
What They Do
Global asset management firm specializing in real estate.
Business Model
The company generates revenue by managing investments in real estate securities, preferred securities, and income solutions through mutual funds, closed-end funds, and institutional portfolios. It serves a diverse clientele that includes individual investors, institutions, and financial advisors, focusing on high-quality strategies that deliver attractive returns through both income and capital appreciation.
Additional Information
Founded in 1986 and headquartered in New York City, Cohen & Steers is recognized for its expertise in international real estate and listed infrastructure assets. The firm emphasizes disciplined research and fundamental analysis, enabling it to adapt to changing market conditions and maintain a significant influence in specialized investment sectors.
Company Information
Sector
Financial Services
Industry
Asset Management
Employees
411
CEO
Mr. Joseph Martin Harvey
Country
United States
IPO Year
2004
Website
www.cohenandsteers.comCohen & Steers Inc. (CNS) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Cohen & Steers (CNS) Moves to Buy: Rationale Behind the Upgrade
Cohen & Steers (CNS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Apr 16, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Cohen & Steers, Inc. (CNS) held its Q1 2026 earnings call, where financial results and company performance were discussed. Further details may be available in the transcript.
Why It Matters
Cohen & Steers, Inc.'s Q1 2026 earnings call provides insights into financial performance, strategic direction, and market outlook, crucial for assessing investment potential and risks.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Cohen & Steers, Inc. (NYSE: CNS) reported its Q1 2026 results on April 16. Details are available on their website under "Investor Relations—Earnings Archive."
Why It Matters
Cohen & Steers' quarterly earnings report can influence stock performance, investor sentiment, and market expectations, impacting investment decisions related to the company.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Cohen & Steers (CNS) has received a Zacks Rank #2 (Buy) upgrade, indicating improved earnings outlook, which may boost the stock's performance in the near term.
Why It Matters
Cohen & Steers' upgrade to Zacks Rank #2 signals positive earnings outlook, likely boosting investor confidence and potentially increasing the stock's value short-term.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Cohen & Steers, Inc. maintains a Buy rating, reporting Q1 EPS of $0.79 and $144M revenue. AUM is $93.1B, with net inflows doubling. Shares yield 4.1%, supported by strong cash reserves.
Why It Matters
Cohen & Steers' strong fund performance, rising AUM, and solid dividend yield indicate potential for growth, attracting investors amid improving macro conditions.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Cohen & Steers, Inc. reported strong Q1 results despite AUM declines. Their focus on high-duration assets makes them sensitive to yield shifts, but potential shipping normalization could benefit them.
Why It Matters
Cohen & Steers' strong Q1 results amid AUM declines highlight resilience. Their focus on hybrids and real estate positions them well for yield shifts, while potential shipping normalization could boost performance.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Cohen & Steers, Inc. (NYSE: CNS) appointed Brad Ispass as Head of U.S. Wealth to enhance its wealth distribution capabilities and support growth in key client segments.
Why It Matters
Leadership changes at Cohen & Steers may signal strategic shifts to enhance U.S. wealth distribution, potentially impacting growth and investor confidence in the firm's future performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About CNS Stock
What is Cohen & Steers Inc.'s (CNS) stock forecast for 2026?
Based on our analysis of 7 Wall Street analysts, Cohen & Steers Inc. (CNS) has a median price target of $70.00. The highest price target is $75.00 and the lowest is $53.00.
Is CNS stock a good investment in 2026?
According to current analyst ratings, CNS has 1 Buy ratings, 1 Hold ratings, and 1 Sell ratings. The stock is currently trading at $66.67. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CNS stock?
Wall Street analysts predict CNS stock could reach $70.00 in the next 12 months. This represents a 5.0% increase from the current price of $66.67. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cohen & Steers Inc.'s business model?
The company generates revenue by managing investments in real estate securities, preferred securities, and income solutions through mutual funds, closed-end funds, and institutional portfolios. It serves a diverse clientele that includes individual investors, institutions, and financial advisors, focusing on high-quality strategies that deliver attractive returns through both income and capital appreciation.
What is the highest forecasted price for CNS Cohen & Steers Inc.?
The highest price target for CNS is $75.00 from John Dunn at Evercore ISI Group, which represents a 12.5% increase from the current price of $66.67.
What is the lowest forecasted price for CNS Cohen & Steers Inc.?
The lowest price target for CNS is $53.00 from at , which represents a -20.5% decrease from the current price of $66.67.
What is the overall CNS consensus from analysts for Cohen & Steers Inc.?
The overall analyst consensus for CNS is neutral. Out of 7 Wall Street analysts, 1 rate it as Buy, 1 as Hold, and 1 as Sell, with a median price target of $70.00.
How accurate are CNS stock price projections?
Stock price projections, including those for Cohen & Steers Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 20, 2026 2:32 AM UTC